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3-Dimensional (3-D) image reconstructionParainﬂuenza virus 5 (PIV5) infects a wide range of animals including dogs, pigs, cats, and humans; however,
its association with disease in humans remains controversial. In contrast to parainﬂuenza virus 3 (PIV3) or
respiratory syncytial virus (RSV), PIV5 is remarkably non-cytopathic in monolayer cultures of immortalized
epithelial cells. To compare the cytopathology produced by these viruses in a relevant human tissue, we
infected an in vitro model of human ciliated airway epithelium and measured outcomes of cytopathology.
PIV5, PIV3 and, RSV all infected ciliated cells, and PIV5 and PIV3 infection was dependent on sialic acid resi-
dues. Only PIV5-infected cells formed syncytia. PIV5 infection resulted in a more rapid loss of infected cells by
shedding of infected cells into the lumen. These studies revealed striking differences in cytopathology of PIV5
versus PIV3 or RSV and indicate the extent of cytopathology determined in cell-lines does not predict events
in differentiated airway cells.omo-2-deoxyuridine; CPE, cy-
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PIV5, previously known as simian virus 5 (SV5), is an enveloped
non-segmented negative strand RNA virus in the family Paramyxovir-
idae. Paramyxoviridae includes many important pathogens of humans
and animals, including human respiratory syncytial virus (RSV),
metapneumovirus, parainﬂuenza virus types 1–4 (PIV1–4), mumps
virus, measles virus, Nipah/Hendra virus, rinderpest virus, and New-
castle disease virus (Karron and Collins, 2006). Most of these viruses
have a limited host range. For example, humans are the only natural
hosts for RSV, PIV1–3, human metapneumovirus, mumps, andmeasles viruses. In contrast, PIV5 has reportedly been isolated from
a wide range of hosts including human, dog, pig, cat, hamster, and
guinea pig (Chatziandreou et al., 2004).
PIV5 was ﬁrst isolated in 1954 from primary monkey kidney cells
but no evidence exists for natural infection of PIV5 in monkeys in the
wild. However, monkeys in captivity quickly seroconvert suggesting
susceptibility upon exposure (Hsiung, 1972; Hull et al., 1956). PIV5
was identiﬁed as the causative agent of kennel cough, a respiratory
illness of dogs (Binn et al., 1967; Cornwell et al., 1976). PIV5 has
been isolated on numerous occasions from human tissues (Goswami
et al., 1984) and neutralizing antibody against PIV5 was readily de-
tectable in non-symptomatic human volunteers (Johnson et al.,
2008). On the one hand, PIV5 has been suggested to be associated
with various human diseases, although it remains controversial
whether or not the virus naturally infects humans and whether or
not it causes disease. On the other hand, it has been suggested that
PIV5 is non-pathogenic in humans and could be a suitable vector for
live viral vaccine applications (Tompkins et al., 2007). PIV5 is not rou-
tinely screened for in studies to identify viruses associated with
human respiratory infections (Lee et al., 2007; Nolte et al., 2007),
and large scale PIV5 surveillance has not been performed. Thus, the
68 L. Zhang et al. / Virology 421 (2011) 67–77prevalence of PIV5 in humans and its impact on human health are
currently unknown.
In typical monolayer cultures of immortalized cells, PIV5 causes a
productive and persistent infection, but does not kill cells or shut off
cellular RNA or protein synthesis (Choppin, 1964). This lack of cyto-
pathology may be largely attributed to the multi-functional PIV5 V
protein. The V protein functions primarily as an interferon antagonist
by binding to MDA-5 to inhibit interferon induction (Andrejeva et al.,
2004) and by binding to STAT1 resulting in its degradation and sup-
pressing interferon signaling (Didcock et al., 1999). V also exhibits
anti-apoptotic activity (Sun et al., 2004) and regulates viral replica-
tion and transcription to optimal levels to avoid detection of viral
RNA by RIG-I, MDA5, toll like receptors, and protein kinase R that
are involved in initiating innate immune responses (Lin et al., 2005).
The ability of PIV5 to readily establish persistent, non-cytopathic in-
fections in vitro may enable the establishment of persistent, non-
pathogenic infections in vivo, although this remains speculative.
PIV5 infection of cell lines is mediated by negatively charged sialic
acid residues present on cell surfaces (Scheid et al., 1972), although
this is largely based on interactions in vitro with immortalized cells
and erythrocytes. The human respiratory airway epithelium is deco-
rated with abundant sialic acids at the lumenal surface (Thompson
et al., 2006; Varki and Varki, 2007). Thus, airway epithelial cells are
likely susceptible to PIV5 infection mediated by sialic acids, similar
to PIV1-3 infection (Bartlett et al., 2008; Schaap-Nutt et al., 2010;
Zhang et al., 2005). To validate this, we use an in vitro model of
human airway epithelium (HAE), generated from human primary
bronchial epithelial cells and differentiated at the air–liquid interface
to reproduce the pseudostratiﬁed mucociliary epithelium of the air-
way as observed for the in vivo counterpart (Fulcher et al., 2005).
Using the HAE model, we found that PIV5 infection of HAE occurs
preferentially at the apical surface and is mediated by interaction
with sialic acids. In comparison to RSV and PIV3, PIV5 was unexpect-
edly more cytopathic, as characterized by enhanced shedding of
infected cells and extensive formation of syncytia.
Results
PIV5 infection of the human airway epithelium (HAE) is preferably apical
and sialic acid-dependent
To monitor PIV5 infection, we used a recombinant PIV5 (strain
W3A) expressing GFP as an extra gene. Apical or basolateral surfaces
of HAE were inoculated with PIV5 (2×106 PFU, MOI of 6) and incu-
bated for 1 h at 37 °C, and GFP ﬂuorescence as an index of PIV5 infec-
tion was monitored over time. We observed that PIV5 infected HAE
with a high efﬁciency from the apical surface, i.e., 66.9%, 69.7%, and
71.2% GFP+ cells en face at 1, 2, and 3 days PI respectively (Fig. 1A).
The lack of substantial increase in the numbers of infected cells over
this period indicated that the infections were near the maximum.
On the other hand, apical infection at a lower MOI (0.01) demonstrat-
ed robust viral spreading (Supplementary Fig. 1). Upon basolateral in-
oculation, only a small number of cells (~1.5%) were infected at 1 day
PI but the number of infected cells increased signiﬁcantly to 20.2%
and 34.7% at 2 and 3 days PI respectively, indicating robust propaga-
tion of PIV5 infection. Thus, similar to our previous reports with RSV
and PIV3, the apical surface of HAE is more susceptible to initial infec-
tion with PIV5 than the basolateral surface; however, unlike RSV
(Zhang et al., 2002) and PIV3 (Zhang et al., 2005), PIV5 exhibited in-
creased tropism for the basolateral surfaces. Similar data has been
obtained with PIV2, another rubulavirus, in an identical culture
model (unpublished observation).
To test whether PIV5 infection in HAE was mediated by sialic
acids, the apical surfaces of HAE were exposed to a broad spectrum
neuraminidase (NA) from Vibrio cholerae (see Materials and methods
for details). The apical surfaces were then inoculated with PIV5 (MOIof 6), and GFP ﬂuorescence visualized at 24 h PI (Fig. 1B). We found
that the NA treatment resulted in a large reduction of PIV5 infection
from 67% to 28% of cells being GFP-positive (Fig. 1C). In contrast,
identical treatment of parallel cultures showed complete abrogation
of PIV3 infection, as shown previously but no effect on RSV infection
(Zhang et al., 2005). To verify that PIV5 infection is solely sialic
acid-dependent, we carried out infections with PIV5, PIV3, and RSV
on two CHO-derived cell lines, the wild type Pro-5 and sialic acid-
deﬁcient Lec2 cells. Monolayer cultures of Pro-5 and Lec2 cells
were inoculated with equal titers of PIV5, PIV3, or RSV (MOI of
10), and the percentages of infected cells (GFP-positive) were quan-
tiﬁed at 24 h PI (Fig. 1D). Both cell types were equally susceptible to
RSV infection, consistent with RSV infection being independent of
sialic acid. In contrast, Lec2 cells – lacking sialic acid – were
completely resistant to infection by PIV5 or PIV3. This showed that
PIV5, like PIV3, is completely dependent on sialic acid for infection
in CHO cells, and possibly in HAE too.PIV5 caused ciliated epithelial cell fusion
To further examine PIV5 infection of HAE, we monitored the fate
of virus-infected cells over time. Replicate HAE cultures were inocu-
lated with equal titers of PIV5, PIV3, or RSV (MOI of 6) and ﬁxed 2,
4, and 7 days PI. To observe the morphology of infected cells, consec-
utive z-stacks (i.e., vertical stacking) of x–y (i.e., horizontal, or en face,
plane) images were acquired with a Zeiss 510 Meta Laser Scanning
Confocal Microscope, and en face views (x–y) were constructed by
maximum z-projection (Fig. 2A). Ciliated cells were visualized by
immune-labeling with β-tubulin-IV antibody (red).The extensive
co-localization of the cilia (red) and GFP-positive cells (shown in
yellow) when viewed at 2 days PI suggested that all three viruses
targeted ciliated cells. Examination of cultures at 4 and 7 days PI in-
dicated a substantial decrease in staining with the tubulin-speciﬁc
antibody, suggesting a loss of either ciliated cells or cilia themselves.
To observe the infected cells in the vertical dimension (x–z), we
resliced the confocal stacks in x–z with ImageJ (Fig. 2B). These im-
ages conﬁrmed that all three viruses exclusively infected ciliated
cells, and all caused the gradual loss of infected ciliated cells within
the period of observation (7 days PI). The x–z sections also revealed
virus-speciﬁc differences in the morphology of virus-infected cells.
A number of the PIV5-infected cells appeared to have fused while
in the epithelium to form GFP-positive multicellular bodies (syncy-
tia), although the nuclei of the fused cells did not congregate togeth-
er in a single cell body as commonly observed in syncytial formation
in non-polarized cells. In contrast, similar cell fusions were absent
from PIV3- or RSV-infected HAE. PIV3-infected ciliated cells retained
typical columnar epithelial cell morphology. In contrast, RSV infec-
tion resulted in rounded ciliated cell morphology. To better capture
the unique morphological features of infected ciliated cells, we per-
formed three-dimensional (3D) reconstruction from confocal z-
stack images (2 days PI) by volume rendering using Volocity soft-
ware. The 3D structures of virus infected epithelial cells were rotat-
ed 360° and captured in a video format (Videos #1–3). The still
images of the 3-D structures captured at 45° angle (with respect to
planes of the epithelia) are shown in the print version. These data
clearly demonstrated the fused columnar PIV5 infected cells, the
non-fused columnar PIV3 infected cells, and the non-fused rounded
RSV infected cells. Interestingly, the PIV5-infected cells appeared to
have persisted in the epithelium during the time frame of this ex-
periment (7 days), although staining for cilia was largely absent by
4 days PI. In contrast, the majority of PIV3- and RSV-infected cells
disappeared from the epithelium by 7 days PI (Fig. 2B). It may be
that the PIV5-infected cells persisted but shed their cilia; alterna-
tively, the PIV5-infected ciliated cells may have been shed while
the remaining non-ciliated cells were subsequently infected by
Fig. 1. PIV5 infection of human airway epithelium is polarized and sialic acid-dependent. (A) Differentiated human airway epithelial (HAE) cell cultures were inoculated with equal
amounts of PIV5 expressing GFP (2×106 PFU per cm2 epithelia; MOI of 6) at either the apical (Ap) or basolateral (BL) surface. GFP expression as an indicator of viral infection was
monitored over time, and representative ﬂuorescence photomicrographs (en face, or x–y plane) were captured at 1, 2, and 3 days post inoculation (PI). Scale bar represents 200 μm.
(B) HAE cultures were treated on the apical surface with either vehicle only or with neuraminidase (NA) from V. cholerae and then were inoculated with 2×106 PFU (per cm2 ep-
ithelia; MOI of 6) of PIV5, PIV3, or RSV (all expressing GFP). Fluorescence photomicrographs were taken en face at 24 h PI (scale bar=50 μm). The percentages of GFP-positive cells
in images of ﬁve random ﬁelds for each treatment were quantiﬁed with ImageJ, and the means±SEM are shown in (C). (D) Wild type Pro-5 and sialic-acid-deﬁcient Lec2 cell
monolayers were infected with PIV5, PIV3, or RSV (MOI of 10). GFP expression was quantiﬁed at 24 h PI and expressed as normalized to Pro-5 cells as 100% (±SEM, n=6 random
ﬁelds each).
69L. Zhang et al. / Virology 421 (2011) 67–77
Fig. 2. Distinctive morphologies of cells infected with PIV5, PIV3, and RSV. (A) Replicate HAE cultures were mock-infected or infected with PIV5, PIV3, or RSV (apical, MOI of 6), ﬁxed
with 4% PFA at 2, 4, and 7 days PI, and immunolabeled with cilia-speciﬁc antibody (β-tubulin IV) (red). Consecutive z-stacks of x–y scanning confocal images were acquired, and en
face x–y views obtained by maximum z-projection are shown. Scale bar represents 30 μm. (B) The stacks of confocal images were re-sliced in the x–z dimension, and representative
images are shown (scale bar=30 μm). Arrows indicates cell fusion in PIV5 infected HAE; and arrow heads points toward rounded RSV-infected cells.
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71L. Zhang et al. / Virology 421 (2011) 67–77PIV5. To reveal these potential differences, we next investigated the
fates of infected ciliated cells.
PIV5 caused greater loss of ciliated epithelial cells than PIV3 or RSV
To determine the consequences of viral infection of HAE, we ex-
amined histological sections at 3 days PI, the day after peak viral in-
fections. For mock-inoculated HAE, the typical pseudostratiﬁed
morphology with abundant ciliated cells was observed (Fig. 3A).
Occasionally, detached cells were observed on the apical surface,
indicative of homeostatic cell turnover. In contrast, for PIV5-
infected HAE, ciliated cells were largely absent by this time point,
3 days PI. Furthermore, a greater number of detached cells were
present on apical surfaces suggesting shedding of infected cells
into the lumenal compartment. This observation was strengthened
by noting the height of the epithelium (thickness), again suggest-
ing signiﬁcant loss of cells from the epithelium inoculated with
PIV5. At these earlier time-points, PIV3-infected HAE exhibited
few obvious changes compared to mock-infected cultures. RSV in-
fection led to the rounding of ciliated cells and to an uneven lumen-
al surface (Figs. 3A and 2B).Video 2.To compare cell loss after virus infection, the numbers of cells
remaining per unit length of the histological sections were quantiﬁed
(Fig. 3B). These data revealed that PIV5-infected HAE contained ap-
proximately one half of the cell numbers for mock-infected HAE, indi-
cating a signiﬁcant and substantial loss of the cells from HAE by
3 days PI. In comparison, PIV3 infection of HAE resulted in a loss of
20% of cells whereas, RSV infection resulted in no signiﬁcant loss of
cells compared to mock-inoculated HAE. Thus, comparisons of cell
loss among these three viruses that all target ciliated cells shows
PIV5 caused the greatest loss of ciliated cells by 3 days PI.
Airway epithelial cell proliferation rates were not affected by viral
infection
Since PIV5 and PIV3 caused signiﬁcant loss of epithelial cells from
HAE, we tested whether the loss of epithelial cells stimulated cellular
proliferation to initiate the repair of the infected epithelium. To quantify
the numbers of dividing cells, HAE cultures, mock-inoculated or inocu-
lated with PIV5, PIV3, or RSV (apical, MOI of 6), were exposed at 3 days
PI to 5-bromo-2-deoxyuridine (BrdU) for 6 h, to identify dividing cells.
In mock-inoculated cells BrdU-label was predominately incorporated
into the nuclei (dark brown) of basal cells (Fig. 4A), indicating the plas-
ticity of this epithelial cell progenitor population. Proliferation rates
were determined by measuring the number of dividing cells per unit
length of epithelium. These rates were found to be comparable among
HAE infected with PIV5, PIV3, or RSV, or mock-inoculated (Fig. 4B).
While PIV5 appeared to modestly increase the cellular proliferation
rate, and PIV3 appeared to modestly reduce the rate, neither change
reached statistical signiﬁcance (pN0.05). Therefore, infections by PIV5,
PIV3, or RSV did not signiﬁcantly alter the rate of cellular proliferation
in HAE.
PIV5 is associated with greater cell shedding than PIV3 and RSV in hu-
man airway epithelium in vitro
We have previously shown PIV3-infected ciliated cells are extrud-
ed onto the apical surface of HAE likely by cell detachment and expul-
sion from the epithelium (Zhang et al., 2009). To compare the extent
of shedding of infected cells after PIV5, PIV3 or RSV infection, we har-
vested the apical washes containing extruded epithelial cells from
HAE inoculated with viruses. To identify shed cells, apical washes
were cyto-centrifuged onto glass slides and stained with Giemsa.
Representative photomicrographs of samples harvested at 1, 4, and
7 days PI are shown in Fig. 5. As expected, ciliated cells were the
Fig. 4. Rates of basal cell proliferation were not affected by viral infection. (A) Replicate
HAE cultures, mock-infected, or infected with PIV5, PIV3, or RSV (apical, MOI of 6),
were labeled with BrdU at 3 days PI followed by ﬁxation with 4% PFA. Parafﬁn-embed-
ded sections were prepared, and the dividing cells were identiﬁed by immunostaining
for BrdU incorporation (dark brown nuclei), while all nuclei were counterstained blue
with hematoxylin (scale bar=10 μm). BrdU positive cells are indicated by red arrows.
(B) The numbers of dividing cells were quantiﬁed by counting the number of BrdU-
positive nuclei in randomly selected images. The mean values (±SEM, n=6 images)
per mm length epithelia are plotted, and each virus-infected group was compared to
mock. No statistical differences were found.
Fig. 3. PIV5 infection caused a substantial loss of epithelial cells. (A) Replicate HAE cul-
tures were mock-infected or infected with PIV5, PIV3, or RSV (apical, MOI of 6), ﬁxed at
3 days PI, parafﬁn-sectioned, and stained with hematoxylin and eosin (H&E). Repre-
sentative images for each treatment are shown. The detached cells are indicated by
black arrows. Note the changes in thickness of the epithelia after certain viral infec-
tions. Scale bar represents 10 μm. (B) The numbers of cells present in the epithelia
were quantiﬁed by counting the numbers of nuclei in the H&E images. The mean
values±SEM per mm length epithelia are plotted (n=6 x–z images). Virus infected
groups were compared to mock. Asterisks (*) denote signiﬁcant statistical differences
(pb0.001) from mock.
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bers of ciliated cells were identiﬁed in washes from mock-inoculated
HAE, signiﬁcantly more cells were present in apical washes from HAE
infected with any of the viruses. Notably, shed cells from PIV5-infected HAE were often observed in large clumps, consistent with
fused infected cells (Fig. 2). In contrast, shed cells from PIV3- and
RSV-infected HAE, were observed as individual cells.
To quantify the differences in cell shedding after infection by dif-
ferent viruses, a quantitative assay for the amount of dsDNA shed
into the apical washes was used. This assay enables the dsDNA
amounts to be used as an index for the numbers of cells shed into
the luminal compartment of HAE, and the dsDNA amounts correlate
well with the numbers of cells shed from the epithelium quantitated
by histological analysis (data not shown). Apical washes were freeze-
thawed three times to release nuclear dsDNA, and the total amounts
of dsDNA present in spin-cleared supernatants quantiﬁed with the
PicoGreen dsDNA reagent (see Materials and methods for details).
Fig. 5. Cytology of shed epithelial cells from viral infected epithelia. Apical washes were harvested from mock-infected or PIV5-, PIV3-, or RSV-infected HAE cultures (apical, MOI of
6), and shed cells were cyto-centrifuged onto glass slides and stained with Giemsa. Representative images for 1, 4, and 7 days PI are shown. Shed cells from PIV5-infected samples
appeared to form cell clumps (syncytia). Note there is a slight difference in scale between 1 day PI versus 4 and 7 days PI. Scale bar represents 20 μm.
73L. Zhang et al. / Virology 421 (2011) 67–77As shown in Fig. 6A, PIV5 caused early and signiﬁcant increase in cell
shedding even at 1 day PI, whereas PIV3 and RSV infection at this
time-point did not increase cell shedding above that measured for
mock-inoculated cultures. Overall, there was a delay in cell shedding
after PIV5 infection with PIV5-mediated cell shedding peaking at
2 days PI and PIV3-mediated or RSV-mediated cell shedding peaking
at 3 days PI. Thus, cell shedding in response to PIV5 infection occurred
earlier and was more severe than in response to PIV3 or RSV.
To establish whether cell shedding led to a loss of epithelium bar-
rier integrity, we next measured the transepithelial electrical resis-
tance (TEER) in mock and virus infected HAE daily for up to 8 days
PI (Fig. 6B). No signiﬁcant changes in TEER in any of the cultures at
1 and 2 days PI were observed, indicating an intact epithelial barrier.
However, the TEER in PIV5-infected HAE dropped signiﬁcantly at
3 days PI, one day after the peak of cell shedding with this virus
(Fig. 6A). This suggested that a compromise in epithelial integrity co-
incided with epithelial cell shedding. PIV3- or RSV-infected HAE also
showed signiﬁcant reduction in TEER compared to mock-inoculated
cultures one day after peak cell shedding (4 days PI). Thus, virus-induced decreases in TEER are likely a direct consequence of virus-
induced cell shedding. Compared to PIV3 and RSV, PIV5 more rapid-
ly and more robustly caused cell shedding of the epithelium.
As part of the innate immune response, epithelial cells produce in-
terferon and other anti-viral cytokines upon viral infection. Interferon,
however, has been suggested to induce the death of virus infected epi-
thelial cells (Schuhmann et al., 2010). To investigate whether cell shed-
ding in response to virus infection is linked to interferon production of
the epithelial cells, we compared the amounts of type I interferon pro-
duced by HAE infectedwith PIV5, PIV3, and RSV. As interferon secretion
from HAE is non-polarized (data not shown), we assessed interferon
levels secreted into the basolateral compartment from mock and virus
inoculated HAE at 1, 2, 3, and 4 days PI. Type I interferon was measured
using an interferon bioassay (seeMaterials andmethods). As predicted,
type I interferon was induced by all viruses with PIV5 (W3A) inducing
the least amount of interferon among the three viruses, and PIV3 induc-
ing almost twice as much interferon than PIV5 or RSV (except at 4 days
PI) (Fig. 6C). The difference in interferon induction was not due to how
viruses were prepared, as the UV-inactivated viruses induced no
Fig. 6. Quantifying the outcomes of viral infections of HAE. (A) Apical washes harvested
on the indicated days from mock-, PIV5-, PIV3-, and RSV-infected HAE (apical, MOI of
6) were subjected to three rounds of freeze and thaw cycles to release nuclear
dsDNA. The amount of dsDNA present in the apical wash as a function of cell shedding
was quantiﬁed with PicoGreen dsDNA reagent (see Materials and methods for details).
The mean values per HAE culture (0.6 cm2) (±SEM, n=3) from 1 to 6 days PI are
shown. (B) Trans-epithelial electrical resistances (TEER) of HAE infected with PIV5,
PIV3, RSV, or mock-infected as above were measured with an EVOM meter on 0 to
8 days PI, and the mean values (±SEM, n=3) are shown. (C) Basolateral media
were collected from the infected HAE from 1 to 4 days PI and type I interferon concen-
trations were determined with a CPE inhibition bioassay (see Materials and methods
for details) (±SEM, n=3).
74 L. Zhang et al. / Virology 421 (2011) 67–77interferon (data not shown). As PIV5 infection results inmore rapid and
robust shedding of the infected cells, the observation that this virus pro-
duces the least interferonwould suggest that interferon is not the caus-
ative factor for mediating epithelial cell shedding in HAE. In contrast to
interferon, we found PIV5 induced the expression of other cyto/chemo-
kines at comparable levels to those induced by PIV3 or RSV infection
(Supplementary Fig. 4).Discussion
The HAE model closely resembles the authentic human airway epi-
thelium and provides a useful in vitro system for evaluating the replica-
tion and cytopathology of respiratory viruses in the absence of the
confounding factors of adaptive and cell-mediated immune responses.
Using the HAE model, we have demonstrated that – in contrast to a
common misconception based on observations using standard mono-
layer cell cultures – RSV does not cause syncytial formation in the air-
way epithelium, consistent with the limited histopathologic ﬁndings
from RSV-infected humans (Zhang et al., 2002). Furthermore, the
growth kinetics and attenuation phenotypes of several attenuated
PIV2 strains in HAE paralleled those in non-human primates in vivo, in-
dicating a close correspondence with this in vitro model (Schaap-Nutt
et al., 2010). In the present study, we used the HAE model to evaluate
infection by the paramyxovirus PIV5. PIV5 is unique among related vi-
ruses for its apparent low cytotoxicity in cell monolayers, even though
PIV5 infects many cell lines from various species. Using the HAE
model, we showed that PIV5 caused greater shedding of virus-infected
ciliated cells compared to the common human respiratory paramyxovi-
rus pathogens PIV3 and RSV that were evaluated in parallel. Although
PIV5 appeared to preferentially infect ciliated cells, it subsequently
caused fusion between the infected ciliated cells with surrounding
cells. This fusogenic property of PIV5was unique among the paramyxo-
viruses that we have tested to date, including RSV, PIV1, PIV2, and PIV3
(Bartlett et al., 2008; Schaap-Nutt et al., 2010; Zhang et al., 2002, 2005).
While PIV5, PIV3, and RSV are all capable of causing syncytia in standard
monolayer cell lines, only PIV5 caused syncytia formation in HAE. The
reason for this difference is unknown and is under investigation.
The viral strains used are critically important when interpreting
experimental results. We chose the W3A strain of PIV5, as among
about a dozen of PIV5 strains known so far, the W3A was the ﬁrst iso-
lated and is the best characterized so far. To date W3A remains the
only strain whose genome has been completely sequenced. It would
be interesting to test a less fusogenic strain such as SER (Tong et al.,
2002), whose fusion protein has a 22 amino acid extension at the cy-
toplasmic domain. Nonetheless, no strains of PIV5 (including W3A)
are linked with human diseases. Our observation that W3A is more
cytopathic than PIV3 and RSV is unexpected, highlighting the need
for further studies in vivo in an appropriate animal model. The RSV
strain (A2) used in our study is a recombinant version of a laboratory
strain; its sequence is nearly identical to the original clinical isolate.
Like the clinical isolate, the recombinant virus caused respiratory
tract disease in chimpanzees (unpublished observations). The PIV3
virus is a recombinant version of JS strain, derived from a clinical iso-
late rather than a laboratory strain. The parental virus used at the Lab-
oratory of Infectious Diseases, National Institutes of Health (Bethesda,
MD) from which the recombinant virus was derived, replicated efﬁ-
ciently in chimpanzees and caused disease (Clements et al., 1991).
We demonstrated that PIV5 infection was sialic acid-dependent.
The residual PIV5 infection after NA treatment indicated that signiﬁ-
cant amounts of PIV5-binding molecules were not removed by V. cho-
lerae NA, even though the same treatment removed all of the PIV3-
binding sialic acids. This could be explained by the observation that
PIV5 recognizes a broader spectrum of sialic acid structures including
the ganglio and the neolacto series, while PIV3 binds only the neo-
lacto series of sialic acids (Suzuki et al., 2001). Alternatively, PIV5
may bind to completely different yet un-identiﬁed molecules on
HAE. We also determined that sulfated polysaccharides did not sup-
port PIV5 infection in HAE. Speciﬁcally, we found that mixing PIV5
with either fucoidan (Supplementary Fig. 2) or heparan sulfate
(data not shown) did not affect the efﬁciency of infection in HAE,
whereas RSV infection was inhibited by fucoidan in a dose dependent
manner. Taken together, HAE may express a broader variety of sialic
acids or other PIV5 receptors than immortalized cell lines, and PIV5
may recognize a broader range of receptors than PIV3, including
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of HAE is most likely dependent on sialic acid residues.
Viral infection signiﬁcantly increased the shedding of epithelial cells
compared to mock-infected HAE (Fig. 6A). This could occur in two dif-
ferent scenarios: (1) virus-induced cell death followed by exclusion
from the epithelium or (2) host cell-mediated acceleration of the shed-
ding of viral infected cells (still alive) as a host defense mechanism to
clear virus infected cells from the epithelium. The second scenario was
found to be more likely based on a trypan blue exclusion assay (data
not shown), which indicated that virus-infected cells in the epithelium,
regardless of their shapes, retained plasma membrane integrity, sug-
gesting that they remained viable. Compared to the robust cytopathol-
ogy in HAE observed after inﬂuenza virus infection (Thompson et al.,
2006; Zhang et al., 2002), the shedding of virus-infected cells in this
study resulted in only moderate disruption to the epithelial integrity,
with PIV5 being more disruptive than PIV3 or RSV.
The BrdU incorporation assay demonstrated that the surface epithe-
lial cells (both ciliated and mucous cells) in HAE did not rapidly divide
after virus infection, suggesting a terminally differentiated state.
Trans-differentiation of ciliated cells to mucous cells after virus infec-
tion has been reported (Tyner et al., 2006) but was not observed in
the present study. In contrast, we found that basal epithelial cells in
HAE did incorporate BrdU, indicative of cell division. Furthermore,
over time, the proliferating basal cells migrated and differentiated into
surface epithelial cells, or remained as a component of the basal cell
layer (self-renewal) (Supplementary Fig. 3). We had anticipated that
the rate of basal cell proliferation might increase upon viral infection
in HAE, in order to compensate for the increased cell shedding. Howev-
er, the rate of basal cell division in HAE remained unchanged by infec-
tion by any of the viruses (Fig. 4). As a consequence, viral infection,
especially by PIV5, resulted in a “thinning” of the epithelium and a pro-
gressive loss of barrier integrity.
PIV5 infection in certain immortalized cell lines demonstrates a
notable lack of cytopathology and in some cases viral persistence. A
human gastric epithelial adenocarcinoma cell line (AGS) was
reported to be persistently infected with PIV5 (Young et al., 2007).
Recently, a human naso-pharyngeal carcinoma cell line (C666-1)
was found to harbor persistent PIV5 infection (personal communica-
tion, Nancy Raab-Traub, UNC). Interestingly, both cell lines showed
unusually high percentages of cell death during routine passages
(unpublished observations), suggesting there was a cost associated
with accommodating PIV5 replication. PIV5 together with PIV2 and
a strain of Sendai virus (SeVpi) were demonstrated to exhibit high ef-
ﬁciencies in establishing persistent viral infections in cell lines (Ito et
al., 2009). These studies suggest PIV5 might persist in vivo, although
this has never been demonstrated.
PIV5 is very permissive in its ability to infect immortalized cell lines in
vitro. It also reportedly has been recovered from diverse mammalian
hosts, including dogs, pigs and humans. The present study indicated
that PIV5 utilizes a wider range of surface sialic acid species as receptor,
which might confer increased host range. PIV5 is a common agent of re-
spiratory tract disease in dogs, but its natural history in other species is
unclear. In particular, as noted, PIV5 has widely been speculated to be a
common agent of infection in humans and a potential agent in a number
of human diseases, but this remains unclear (Introduction). A counter-
vailing opinion is that PIV5 infection of humans likely is benign, and
that PIV5 might be suitable as a vaccine vector for human use. The pre-
sent study showed that PIV5 infection of HAE shared some characteris-
tics with that of the common human pathogens RSV and the PIVs, such
as tropism for the surface ciliated epithelial cells. Given the wide specu-
lation that PIV5 infection might be persistent or benign, we had antici-
pated that PIV5 would be less cytopathic in HAE than RSV and the
human PIVs, which can cause serious respiratory tract disease in
humans. For example, persistent infection is often associated with re-
duced viral pathogenesis (Rima and Martin, 1976) and decreased fuso-
genic activity of virus proteins (Sarmiento et al., 2009). However, theconverse was observed: in contrast to RSV and the human PIVs, PIV5
was substantially fusogenic and invasive, caused increased cell shedding,
resulted in a thinning of the epithelium, and caused a greater compro-
mise to epithelial integrity. This illustrates the uncertainty of predicting
pathogenesis and persistence based on properties observed inmonolay-
er cultures of immortalized cells. HAE cultures also represent an in vitro
system, but they recreate a mucociliary pseudostratiﬁed tissue that
closely resembles authentic airway epithelium in structure and function,
and uniquely provide an evaluation of direct viral cytopathology in the
absence of immune destruction.
In summary, we showed PIV5 efﬁciently infects human ciliated
airway epithelial cells. Infection was mediated primarily by surface
sialic acid residues and was associated with greater cytopathology
than PIV3 or RSV assayed directly in parallel. This study shows
that primary human epithelial cells are efﬁciently infected by
PIV5, consistent with the possibility that humans might be a per-
missive host for the virus. However, the increased pathogenesis ob-
served in HAE cultures – compared to the common viral agents of
respiratory tract disease RSV and the human PIVs – raises the possi-
bility that PIV5 infection of the respiratory tract might not be be-
nign. Future in vivo studies will be required to shed light on these
questions.Material and methods
Cells and viruses
Human lung carcinoma cells A549 (ATCC# CCL-185) were grown in
Dulbecco's Modiﬁed Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and penicillin–streptomycin (Pen-Strep).
CHO derivatives Pro-5 (ATCC# CRL-1781) and Lec2 (ATCC# CRL-1736)
cells were grown inMinimum Essential Medium (MEM)α supplemen-
ted with 10% FBS, 40 μg/ml proline, and Pen-Strep. The human airway
epithelial cell culture model (HAE) was generated as described previ-
ously (Fulcher et al., 2005). Recombinant PIV5 was derived from W3A
strain and contained a GFP reporter gene between HN and L (He et al.,
1997). RSV (Hallak et al., 2000) and PIV3 (Zhang et al., 2005) are recom-
binant GFP-expressing viruses based on the RSV A2 and PIV3 JS strains
respectively. Note all viruses used in these studies express GFP.Enzymatic removal of sialic acids from HAE with neuraminidase (NA)
treatment
The sialic acid residues on the apical surface of HAE were removed
by treatment with NA from Vibro cholerae (Sigma N-6514). The apical
surface of HAE was rinsed three times with PBS to remove accumulat-
ed mucus. NA, diluted with serum-free medium to a ﬁnal concentra-
tion of 200 mU/ml, was inoculated on the apical surface of HAE and
incubated for 3 h at 37 °C, followed by NA removal and washing
with PBS. Viral infections were carried out immediately after NA
treatment.Identiﬁcation of dividing cells by BrdU labeling and immunohistochemical
staining
Replicate HAE cultures were mock-infected or infected with virus
(MOI of 6), incubated for 3 days, and labeled by incubation with
10 μM 5-bromo-2-deoxyuridine (BrdU) (Invitrogen) for 6 h followed
by ﬁxation with 4% paraformaldehyde (PFA) at 4 °C overnight. The
ﬁxed HAE was then parafﬁn-embedded and sectioned (5 μm). BrdU-
labeled nuclei were immunostained using a Zymed BrdU Staining
Kit (Invitrogen) (shown in dark brown) and cell nuclei counter-
stained with hematoxylin (shown in blue).
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Phenol red-free serum-free DMEMwas added to the apical surfaces
ofmock or virus-infectedHAE cultures (0.4 ml per 12-diameter culture)
at the indicated days PI and allowed to incubate for 30 min before
being harvested with a pipette. Half of the solution (0.2 ml) was
used for measuring dsDNA content (see below) and the rest (0.2 ml)
was cyto-centrifuged at 700×rpm for 4 min onto glass slides using a
StatSpin CytoFuge 2 (Iris Sample Processing). The slides were air-
dried, ﬁxed in 4% PFA, and stained with Giemsa by the UNC CF Center
Histology Core.
Photomicrographic image capture and processing
Fluorescence and bright ﬁeld photomicrographs were captured by
using a Leica DMIRB Inverted Fluorescent Microscope equipped with
a Q-Imaging Retiga 1300 CCD camera. Confocal x-z images and z-
stacks were acquired with a Zeiss 510 Meta Laser Scanning Confocal
Microscope. X-z reslicing of the confocal z-stack was performed
with the ImageJ software (NIH), and 3D image reconstructions by vol-
ume rendering were carried out with Volocity software (Improvision/
Perkin Elmer). Other image processing and calculations were per-
formed with Adobe Photoshop (Adobe).
Quantiﬁcation of dsDNA for cell shedding analysis
The total amount of dsDNA present in the apical washes of HAE
was quantiﬁed in 96-well plate format using a Quant-iT PicoGreen
dsDNA Kit (Invitrogen #P11496). Brieﬂy, washes from HAE cells
were freeze-and-thawed three times to release nuclear dsDNA, and
cellular debris was removed by centrifugation (2500 g for 10 min).
The supernatants were then diluted ﬁve fold with TE buffer (10 mM
Tris–Cl, pH 7.5, 1 mM EDTA) in 96-well plates followed by the addi-
tion of diluted PicoGreen dsDNA reagent. Each sample was run in du-
plicate, and ﬂuorescence signals were read with a Tecan Inﬁnite
M1000 Microplate Reader (Ex/Em 480/520 nm).
Type I interferon (IFN) bioassay
Type I IFN levels in cell culture supernatants were determined by a
CPE inhibition bioassay using A549 cells and encephalomyocarditis
virus (EMCV) (ATCC# VR-129B) as described previously (Shabman et
al., 2008). Brieﬂy, serial two-fold dilutions of test supernatants in dupli-
cate were cultured with A549 cells (2×104 per well in 96-well plates)
for 24 h. Cells were then infected with EMCV at a MOI of 5; 24 h later
the plates were stained for attached cells with 0.1% crystal violet/20%
methanol. The bioassay plates were scored for 50% CPE as an indicator
of IFN concentration. Each plate also contained an internal IFN standard,
the recombinant human IFN-β (Invitrogen PHC4244), which had been
calibrated against the NIH human IFN-β reference standard (Gb23-
902-531). The deduced IFN concentrations in test samples were
expressed as international units (IU) per ml.
Statistics
Statistical analyses, including student's t test and one-way analysis
of variance (ANOVA) (Holm-Sidak method), were performed using
SigmaStat 3.11 (Systat Software Inc). Statistical signiﬁcance was de-
ﬁned as pb0.05 unless otherwise noted.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2011.08.020.
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